This study investigatesand comparesthe responsesof 132 opiate addictsto a 10-day or a 21-dayin-patient oralmethadone withdrawal regime. Forbothgroups, symptom severity (ontheOpiateWithdrawal Scale) steadily increased through themethadone withdrawal phase, and peakednearthe point of completionof the prescribeddrug, decliningslowly thereafter. Patientson the 10-day programmereportedsignificantlyhigherpeakwithdrawal scoresthan thoseonthe21-dayprogramme. Although theproportions whocompleted detoxification were similar,there was a significantlyhigherdrop-outrate immediatelyafter detoxificationfor the 10-day group. The possiblebenefits and handicapsof the two withdrawal schedulesare consideredand recommendationsare proposedfor further refinementof the presentwidely adopted approach.
detoxification alone has been shown to be ineffective for long-term abstinence (Lipton & Maranda, 1983) , the withdrawal phase is a necessary but not sufficient condition for this. One of the most widely used methods of withdrawal involves gradually reducing doses of oral methadone. This technique has been popular since the early work of Isbell & Vogel (1948) , and is probably the most common procedure; it has been suggested that as many as 10 000 opiate addicts may be withdrawing on methadone at any one time in the United States (Kleber et al, 1980) . It is clear that methadone has had considerable success as a withdrawal agent. Previous British studies found that more than 80Â°lo of in-patient samples could be successfully withdrawn from drugs using methadone (Gossop et al, 1986 (Gossop et al, , 1987a ).
However, it has also been suggested that the wide spread clinical acceptance of methadone withdrawal schedules may have diverted attention from its weaknesses (Gossop & Bradley, 1984) . One problem is that they reduce but do not eliminate withdrawal symptoms. The withdrawal response during treatment has been likened to a mild case of influenza (Kleber, 1981) , and has been described as being objectively mild but subjectively severe. Gossop et al (1982) found that many opiate addicts were frightened of withdrawaland such beliefs and expectations should not be underestimated: these factors are associated with the subsequentseverityof withdrawalsymptoms, and they are more closely relatedto symptom severity than, for instance, drug dosage (Phillips et al, 1986 ).
Another drawback of methadone withdrawal is that residual symptoms take a long time to resolve.
In a comparison of methadone and electrostimulation procedures, Gossop, et al(1984) found that although methadone was more effective in reducing symptom severity, it led to a prolonged withdrawal response, with patients still reporting moderate discomfort 10 days after detoxification. This protracted withdrawal response was confirmed by a later, more extensive trial, which found that patients were still experiencing significantly more symptoms than controls two weeks after the discontinuation of methadone (Gossop et al, 1987b) .It wassuggested thatdifferentmethadone regimes might reduce the severity and duration of withdrawal symptoms and be more acceptable to patients. The present study looks at these suggestions, by comparing the responses of addicts on a 10-day and a 21-day withdrawal programme. (Gossop et a!, 1984; Phillips et a!, 1986; Gossop eta!, l987b) . The OWS items allload heavilyon a singleâ€˜¿ withdrawal' factor,and the total OWSscorecorrelatesextremelyhighlywiththe factorscore, indicatingthat the total withdrawalscoreisa validmeasure of withdrawal; inaddition, thescalediscriminates effectively in the measurement of withdrawal and post-withdrawal states (Bradley et a!, 1987 ,and on withdrawal days 1, 5, 15, 25, 35) , and the â€˜¿ withdrawal curves' for both groupscan be plotted and compared, and the score for the two groups compared in a numberof important respects(notably with regardto maximum withdrawal severity).
Subjects

Results
Total withdrawal severity scores for both groups are shown in Fig. 1 . The mean total scores for both samples are plotted against time. It can be seen that the curves for thegroupsaresimilar.In both, the meandailyscorerises from a similarstartingpoint at admissionto a peak around the end of the methadone phase of withdrawal. For the 21-day group, the peak is on day 20. For the 10-day group, thepeakisonday13,soonafterthelastdoseof methadone. The data were also analysed with regard only to those symptoms rated as â€˜¿ severe', as a â€˜¿ severe' score on one symptom may indicate a level of suffering that is not equivalent to experiencing mild discomfort on a number of measures. The mean daily severe scores were calculated and plotted for both groups. The resultinggraphsreflected the samepattern of symptomsshownin Fig. 1total Withdrawal scores increased in severity to peak after the end of the methadone phase (on day 13), and showed a gradual decline thereafter. In the 21-day group, symptoms began to increase at about day 10, peaked on day 20 (the last day on which they received methadone), and declined thereafter. In both groups, withdrawal symptoms were at their most severe at about the end of the gradual methadone reduction phase. This observation was confirmed both by measures based on total withdrawal scores, and by measures of severe symptoms only. Although the difference between peak withdrawal scores of the two groups is statistically significant, it is not clear whether it is clinically important.
There was also a statistical difference between the two groups with regard to the time course of withdrawal. For those patients withdrawn over 10 days, the period of greatest discomfort occurred earlier, but was matched by an earlier recovery from withdrawalsymptoms. From a purely scientific point of view, this observation is relatively trivial, but it has clinical significance (it also has clear financial implications for treatment). Even though the duration of the withdrawal syndrome is much the same for both treatments in terms of severe symptoms, it may be important that patients should feel that they have recovered from withdrawal as quickly as possible, especially if drug-free and symptom-free functioning is required for some further stage of treatment. One of the greatest drawbacks of the 21-day withdrawal schedule is that it leads to a protracted residual withdrawal response, with patients not fully recovered until 40 days after the beginning of withdrawal (Gossop et al, 1984 (Gossop et al, , 1987 . The same residual withdrawal effect can be seen in the present study for the 10-day reduction scheme. It is possible that this effect will turn out to be one of the greatest disadvantages of methadone as a withdrawal agent.
There was no difference between the 10-day and 21-day programmes with regard to completion rates for detoxification. Both were reasonably effective, with between 70Â¾and 79Â°lo of the groups reaching a drug-free state. There was, however, a marked difference in terms of drop-out rates over the 10 days immediately after the end of detoxification, with 30Â¾ of the 10-day subjects discharging themselves from treatment, compared with 17.5Â¾of the 21-day subjects. There are many variables unrelated to with drawal that could have a powerful influence upon treatment retention, and about which we have no data in this study (including social interaction between patients on the unit, staff-patient relations, changes in patient characteristics, or treatment procedures across time). For this reason, caution is needed in attributing drop-out rates after detoxification simply to the withdrawal effects. Nonetheless, there must be some worries about the 10-day programme in this respect.
It is clear from the response to both withdrawal programmes that the period around the end of the methadone reduction schedule is the period of greatest discomfort for addicts. Some patients may belive that the last day of methadone should coincide with the last day of withdrawal discomfort, in which case the presence and severity of the residual symptoms may be especially unsettling. It has been shown that anxiety-related factors are associated with the severity of withdrawal (Philips et al, 1986) , and that giving accurate but reassuring information can reduce distress (Green & Gossop, 1988) . It would seem desirable to pay attention to the psycho logical factors associated with withdrawal, and include reassurance and information to reduce withdrawal distress and any subsequent drop-out from treatment after the actual detoxification procedure is complete. This study has shown that it is possible to reduce the duration of the active withdrawal phase of treatment from 21 to 10 days using an oral methadone reduction scheme. This has been achieved without affecting detoxification completion rates, although there is a worrying suggestion of a higher drop-out rate subsequently. It would seem desirable to look for a procedure with the advantages of the shorter schedule but without its drawbacks. It is possible that improvements in the methadone withdrawal response could be achieved through the use of an exponential dose reduction rather than a linear schedule, and through the routine provision of information during withdrawal. Such modifications might be expected to have the effect of reducing peak severity and/or the residual withdrawal response. These suggestions are readily amenable to empirical investigation and deserve further research.
